Author:
Börgermann C.,Chun Felix K.-H.,Bastian Patrick J.,Fischer K.,Fornara P.,Fröhner M.,Graefen M.,Haese A.,Hammerer P.,Heine K.,Heß J.,Hoda M.R.,Huland H.,Köllermann J.,Loertzer H.,Luboldt H.-J.,Miller K.,Rübben H.,Schlomm T.,Schostak M.,Schrader M.,Schwarz R.,Thederan I.,Wirth M.,Wolff J.M.,Hansen J.
Publisher
Springer Berlin Heidelberg
Reference1201 articles.
1. Adami HO, Kuper, H, Andersson SO et al. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 12: 872 (2003)
2. Ahn J, Peters U, Albanes D et al. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 100: 796 (2008)
3. Ahonen MH, Tenkanen, L, Teppo L et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11: 847 (2000)
4. Albanes, D, Blair, A, Taylor PR Physical activity and risk of cancer in the NHANES I population. Am J Public Health 79: 744 (1989)
5. American Cancer Society (2003) Cancer facts and figures 2003, Atlanta, GA. 2003)